Tezepelumab for severe asthma in Korean patients
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a drug called tezepelumab to see if it helps control severe asthma in adults. It may be an option if your asthma is hard to manage with current treatments and you have frequent symptoms or flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 79 years old.
- You have severe asthma that needs high-dose inhaled steroids or regular oral steroids to control.
- Your asthma is not well controlled, meaning you have symptoms often, need steroids for flare-ups at least twice last year, or were hospitalized for asthma last year.
- You have a chronic cough from asthma that you rate at least 30 out of 100 on a scale.
- You have had a positive bronchial challenge test (or a positive response to a bronchodilator) to confirm asthma.
- You have not used other biologic drugs for asthma in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
This trial tests a new medicine, QL2302, to see how well it works compared to an approved treatment called Tezspire for people with severe asthma. If you have asthma that is not well controlled despite using daily inhalers and other medications, you may be able to join.
This trial tests a new biologic drug (tezepelumab) to see if it improves symptoms in people with both chronic sinusitis with nasal polyps and severe asthma. The goal is to reduce inflammation and help you breathe better. Participants must not have had prior sinus surgery.
This trial tests a new drug called tozorakimab for adults whose asthma is not well controlled despite using medium-to-high dose inhaled steroids. The study aims to find the best dose and see if it reduces asthma attacks.
This study tests a new medicine called depemokimab, given as an injection, to see if it can reduce asthma attacks in people with a specific type of asthma (type 2 high). If you have had asthma for several years and have had recent attacks despite using regular inhalers, this trial might be an option for you.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.